Capital Markets: Equity (International Firms)
China
5 years ranked

Greater China Region 2026
Provided by Skadden, Arps, Slate, Meagher & Flom and Affiliates
Corporate
Admitted in Hong Kong and England & Wales. Currently practising in Hong Kong.
Recent publications include:
HKEX and SFC Reduce Barriers for Specialist Technology Company IPOs and De-SPACs, August 2024;
HKEX Consults on New Corporate Governance Reforms, July 2024
HKEx Publishes Consultation Conclusions on Enhancing Climate-Related Disclosure, May 2024
HKEx Announces Consultation Conclusion for New Treasury Shares Rules, April 2024
Paloma Wang is co-head of the firm’s China practice, focusing on public listings and other corporate matters. She represents both issuers and underwriters in initial public offerings on the Hong Kong Stock Exchange, advising investors and corporates on private equity investments and counseling listed issuers on compliance, general corporate and regulatory matters.
Provided by Chambers
Paloma Wang co-heads the firm's China practice. She wins acclaim for her expertise advising issuers and underwriters on biotech IPOs. She serves a host of clients from Skadden's base in Hong Kong.
Provided by Chambers
She's very hardworking and very good at client service.
She has every experience we need and gives helpful advice and support to us.
Paloma is a very experienced senior partner.
Chambers is the leading data and intelligence partner for the legal sector.